Novavax COVID vaccine heads to U.S. FDA advisory committee

Advisers to the U.S. Food and Drug Administration on Tuesday will consider whether to recommend Novavax Inc's (NVAX.O) COVID-19 vaccine for adults, which the drugmaker hopes can become the shot of choice among some American vaccine skeptics. Novavax's shot is a more traditional type of vaccine employing technology that has been used for decades to combat diseases including Hepatitis B and influenza.
Read more: https://www.reuters.com/world/us/novavax-covid-vaccine-heads-us-fda-advisory-committee-2022-06-07/?source=Snapzu